The challenge of matching assays to biology in DNA damage response biomarkers for response to radiotherapy in bladder cancer.
作者信息
Desai Neil B, Bagrodia Aditya
机构信息
Department of Radiation Oncology, GZA Sint-Augustinus Hospital, Oosterveldlaan 24, Wilrijk (Antwerp), Belgium.
Department of Urology, University of Texas Southwestern, Dallas, TX, USA.
出版信息
Transl Androl Urol. 2019 Dec;8(Suppl 5):S514-S516. doi: 10.21037/tau.2019.07.05.
Abstract
摘要
相似文献
1
The challenge of matching assays to biology in DNA damage response biomarkers for response to radiotherapy in bladder cancer.
Transl Androl Urol. 2019 Dec;8(Suppl 5):S514-S516. doi: 10.21037/tau.2019.07.05.
2
CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer.
J Exp Clin Cancer Res. 2019 Feb 20;38(1):90. doi: 10.1186/s13046-019-1087-1.
3
Adenovirus-mediated downregulation of the ubiquitin ligase RNF8 sensitizes bladder cancer to radiotherapy.
Oncotarget. 2016 Feb 23;7(8):8956-67. doi: 10.18632/oncotarget.6909.
4
Early and late damage in the mouse bladder after radiation combined with cyclophosphamide or cisplatinum, evaluated by two different functional assays.
Acta Oncol. 1993;32(6):679-87. doi: 10.3109/02841869309092452.
5
Epidermal growth factor receptor status predicts local response to radical radiotherapy in muscle-invasive bladder cancer.
Clin Oncol (R Coll Radiol). 2006 Nov;18(9):702-9. doi: 10.1016/j.clon.2006.08.003.
6
Predictive biomarkers for drug response in bladder cancer.
Int J Urol. 2019 Nov;26(11):1044-1053. doi: 10.1111/iju.14082. Epub 2019 Aug 1.
7
Comparison of margins, integral dose and interfraction target coverage with image-guided radiotherapy compared with non-image-guided radiotherapy for bladder cancer.
Clin Oncol (R Coll Radiol). 2014 Aug;26(8):497-505. doi: 10.1016/j.clon.2014.03.007. Epub 2014 Apr 13.
8
Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.
BJU Int. 2012 Dec;110(11 Pt C):E1228-36. doi: 10.1111/j.1464-410X.2012.11564.x. Epub 2012 Oct 9.
9
Determining optimal planning target volume and image guidance policy for post-prostatectomy intensity modulated radiotherapy.
Radiat Oncol. 2015 Jul 26;10:151. doi: 10.1186/s13014-015-0467-8.
10
MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene.
Cancer Lett. 2015 Feb 1;357(1):105-113. doi: 10.1016/j.canlet.2014.11.002. Epub 2014 Nov 11.
引用本文的文献
1
DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma.
Front Endocrinol (Lausanne). 2022 Jul 26;13:882431. doi: 10.3389/fendo.2022.882431. eCollection 2022.
2
Review of Experimental Studies to Improve Radiotherapy Response in Bladder Cancer: Comments and Perspectives.
Cancers (Basel). 2020 Dec 30;13(1):87. doi: 10.3390/cancers13010087.
本文引用的文献
1
MRE11 as a Predictive Biomarker of Outcome After Radiation Therapy in Bladder Cancer.
Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):809-818. doi: 10.1016/j.ijrobp.2019.03.015. Epub 2019 Mar 15.
2
The role of biomarkers in bladder preservation management of muscle-invasive bladder cancer.
World J Urol. 2019 Sep;37(9):1767-1772. doi: 10.1007/s00345-018-2480-7. Epub 2018 Sep 14.
3
Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer.
Clin Cancer Res. 2019 Feb 1;25(3):977-988. doi: 10.1158/1078-0432.CCR-18-1001. Epub 2018 Jul 6.
4
Molecular and Clinical Insights into the Role and Significance of Mutated DNA Repair Genes in Bladder Cancer.
Bladder Cancer. 2018 Jan 20;4(1):9-18. doi: 10.3233/BLC-170129.
5
Genomic characterization of response to chemoradiation in urothelial bladder cancer.
Cancer. 2016 Dec 1;122(23):3715-3723. doi: 10.1002/cncr.30219. Epub 2016 Aug 1.
6
Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233.
Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):67-74. doi: 10.1016/j.ijrobp.2015.09.030. Epub 2015 Sep 28.
7
Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer.
Eur Urol. 2015 Dec;68(6):959-67. doi: 10.1016/j.eururo.2015.07.009. Epub 2015 Aug 1.
8
Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma.
Cancer Discov. 2014 Oct;4(10):1140-53. doi: 10.1158/2159-8290.CD-14-0623. Epub 2014 Aug 5.
9
Post-transcriptional regulation of MRE11 expression in muscle-invasive bladder tumours.
Oncotarget. 2014 Feb 28;5(4):993-1003. doi: 10.18632/oncotarget.1627.
10
Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer.
Ann Oncol. 2014 Apr;25(4):877-883. doi: 10.1093/annonc/mdu014. Epub 2014 Mar 12.
Zotero 插件